Bone alkaline phosphatase decreased by 30% at 8 weeks after the second infusion compared with the baseline of the first infusion, but this also did not reach statistical significance.
← all excerpts
Metabolic effects of pamidronate in patients with metastatic bone disease.
1
—
—